This $155,520 Project Grant awarded by the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research program) aims to address cancer screening disparities among transgender and gender diverse (TGD) individuals. The key products and services to be delivered include:
-
Analyzing a large insurance claims database to establish benchmark data on actual cancer screening mammography rates among TGD individuals and identify factors associated with screening or lack thereof. This will provide crucial insights to inform future initiatives.
-
Conducting qualitative interviews with TGD individuals aged 40+ to directly understand their perspectives on cancer screening and identify ways to improve accessibility.
This research effort, led by the Mayo Clinic, seeks to develop the principal investigator's expertise in cancer care for the underserved TGD population and ultimately help ensure they receive the same life-saving benefits of cancer screening as the general population. The award period runs from August 2024 to February 2028.
Generated 3/4/25, 8:12 AM